Pharmacokinetic (PK) and Toxicokinetic (TK) studies to support the early stages of the drug discovery process. Routes are often I.V. AND the proposed clinical route and conducted in rodents and non-rodents. TK/PK studies are often single-dose, but can be repeat-dose.
We provide the following benefits to customers seeking PK screening:
- Ability to meet aggressive timelines for outsourced PK programs
- Short lead time for study initiation
- Rapid turnaround times
- Flexible scheduling to allow last-minute changes to study protocol
- Standardized, abbreviated protocols and reporting methods